These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7857659)

  • 1. Production of a bioactive high molecular weight transforming growth factor beta-like molecule by human malignant glioma cell lines.
    Tucker MA; Gillespie GY
    Growth Factors; 1994; 11(2):153-62. PubMed ID: 7857659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of thrombospondin-1 in the activation of latent transforming growth factor-beta in malignant glioma cells.
    Sasaki A; Naganuma H; Satoh E; Kawataki T; Amagasaki K; Nukui H
    Neurol Med Chir (Tokyo); 2001 May; 41(5):253-8; discussion 258-9. PubMed ID: 11396305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial characterization of glioma-derived growth factor 2: a novel mitogenic activity from human cell line D-54 MG.
    Lyon E; Gillespie GY
    J Neurooncol; 1993 Aug; 17(2):99-109. PubMed ID: 8145064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain.
    Weller M; Fontana A
    Brain Res Brain Res Rev; 1995 Sep; 21(2):128-51. PubMed ID: 8866671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.
    Tritschler I; Gramatzki D; Capper D; Mittelbronn M; Meyermann R; Saharinen J; Wick W; Keski-Oja J; Weller M
    Int J Cancer; 2009 Aug; 125(3):530-40. PubMed ID: 19431147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of transforming growth factor-beta secretion from malignant glioma cells by interleukin-1 beta.
    Naganuma H; Sasaki A; Satoh E; Nagasaka M; Nakano S; Isoe S; Nukui H
    Neurol Med Chir (Tokyo); 1996 Mar; 36(3):145-50. PubMed ID: 8869149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to growth inhibition by transforming growth factor-beta in malignant glioma cells with functional receptors.
    Isoe S; Naganuma H; Nakano S; Sasaki A; Satoh E; Nagasaka M; Maeda S; Nukui H
    J Neurosurg; 1998 Mar; 88(3):529-34. PubMed ID: 9488308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TM-1 cells from an established human malignant glioma cell line produce PDGF, TGF-alpha, and TGF-beta which cooperatively play a stimulatory role for an autocrine growth promotion.
    Kurimoto M; Endo S; Arai K; Horie Y; Nogami K; Takaku A
    J Neurooncol; 1994; 22(1):33-44. PubMed ID: 7714549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides.
    Jachimczak P; Hessdörfer B; Fabel-Schulte K; Wismeth C; Brysch W; Schlingensiepen KH; Bauer A; Blesch A; Bogdahn U
    Int J Cancer; 1996 Jan; 65(3):332-7. PubMed ID: 8575854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal inhibition of prostatic epithelial cell proliferation not mediated by transforming growth factor beta.
    Kooistra A; van den Eijnden-van Raaij AJ; Klaij IA; Romijn JC; Schröder FH
    Br J Cancer; 1995 Aug; 72(2):427-34. PubMed ID: 7543773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cells.
    Platten M; Wild-Bode C; Wick W; Leitlein J; Dichgans J; Weller M
    Int J Cancer; 2001 Jul; 93(1):53-61. PubMed ID: 11391621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretion of transforming growth factor-beta 1 and -beta 2 by malignant glioma cells.
    Sasaki A; Naganuma H; Satoh E; Nagasaka M; Isoe S; Nakano S; Nukui H
    Neurol Med Chir (Tokyo); 1995 Jul; 35(7):423-30. PubMed ID: 7477684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and partial purification of growth factors with TGF-like activity from human malignant gliomas.
    Rutka JT; Rosenblum ML; Stern R; Ralston HJ; Dougherty D; Giblin J; DeArmond S
    J Neurosurg; 1989 Dec; 71(6):875-83. PubMed ID: 2585080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Growth factors produced by rat glioma cells: activities of transforming growth factors].
    Kanno H; Shinonaga M; Kuwabara T; Umeda M
    No To Shinkei; 1989 Sep; 41(9):905-9. PubMed ID: 2590559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human glioblastoma cell derived transforming growth factor-beta 2: evidence for secretion of both high and low molecular weight biologically active forms.
    Bodmer S; Huber D; Heid I; Fontana A
    J Neuroimmunol; 1991 Oct; 34(1):33-42. PubMed ID: 1894732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of irradiation on transforming growth factor-beta secretion by malignant glioma cells.
    Satoh E; Naganuma H; Sasaki A; Nagasaka M; Ogata H; Nukui H
    J Neurooncol; 1997 Jul; 33(3):195-200. PubMed ID: 9195490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High molecular weight transforming growth factor beta is excreted in the urine in active nodular sclerosing Hodgkin's disease.
    Newcom SR; Tagra KK
    Cancer Res; 1992 Dec; 52(24):6768-73. PubMed ID: 1458464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.
    Wick W; Grimmel C; Wild-Bode C; Platten M; Arpin M; Weller M
    J Neurosci; 2001 May; 21(10):3360-8. PubMed ID: 11331365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.
    Ashley DM; Kong FM; Bigner DD; Hale LP
    Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved bioassay for the detection of transforming growth factor-beta 1 and beta 2 in malignant gliomas.
    Naganuma H; Sasaki A; Satoh E; Sakihama T; Tasaka K; Nukui H
    Neurol Med Chir (Tokyo); 1994 Mar; 34(3):143-9. PubMed ID: 7516043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.